The Korean journal of internal medicine

  • 제26권1호
  • /
  • Pages.34-40
  • /
  • 2011
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Factors Associated with Survival in Patients with Primary Duodenal Adenocarcinoma

  • Chung, Woo-Chul (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Paik, Chang-Nyol (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Jung, Sung-Hoon (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Lee, Kang-Moon (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Kim, Sang-Woo (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Chang, U-Im (Department of Internal Medicine, The Catholic University of Korea School of Medicine) ;
  • Yang, Jin-Mo (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
  • 발행 : 2011.03.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: The prognostic factors in primary duodenal adenocarcinoma remain controversial. This study evaluated the prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Methods: From March 1996 to June 2008, the medical records of 30 patients with a final diagnosis of primary duodenal epithelial malignancy seen at two referral centers were reviewed retrospectively. The prognostic factors for survival were evaluated 6 months and 1, 2, and 5 years after the diagnosis. Results: The median survival was 5.7 months. The survival rate was 46.7% (14/30), 16.7% (5/30), 10% (3/30), and 6.7% (2/30) at 6 months and 1, 2, and 5 years, respectively. Multivariate analysis showed that cancer-directed treatment, including curative surgery or chemotherapy, was a common independent risk factor at all follow-up times. Total bilirubin, cytology, and TNM stage were independent risk factors for survival at 1, 2, and 5 years. The white blood cell count was an independent risk factor at 1 year only. The actuarial probability of survival in patients undergoing cancer-directed treatment was significantly higher than in those without treatment at 6 months (71.4 vs. 25.0%, p < 0.01), 1 year (28.6 vs. 6.3%, p < 0.01), 2 years (21.4 vs. 0%, p < 0.01), and 5 years (14.3 vs. 0%, p < 0.01). Conclusions: The prognostic factors in patients with primary duodenal adenocarcinoma were total bilirubin, TNM stage, cytology, and cancer-directed treatments until the 5-year follow-up. Especially, cancer-directed treatments improved patient survival.

키워드

참고문헌

  1. Spira IA, Ghazi A, Wolff WI. Primary adenocarcinoma of the duodenum. Cancer 1977;39:1721-1726. https://doi.org/10.1002/1097-0142(197704)39:4<1721::AID-CNCR2820390450>3.0.CO;2-M
  2. Bucher P, Gervaz P, Morel P. Long-term results of radical resection for locally advanced duodenal adenocarcinoma. Hepatogastroenterology 2005;52:1727-1729.
  3. Lillemoe K, Imbembo AL. Malignant neoplasms of the duodenum. Surg Gynecol Obstet 1980;150:822-826.
  4. Moss WM, McCart PM, Juler G, Miller DR. Primary adenocarcinoma of the duodenum. Arch Surg 1974;108:805-807. https://doi.org/10.1001/archsurg.1974.01350300047013
  5. Pitt HA. Duodenal cancer: endoscopic or surgical resection? J Clin Gastroenterol 2003;37:356-357. https://doi.org/10.1097/00004836-200311000-00002
  6. Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg 1996;183:89-96.
  7. Hung FC, Kuo CM, Chuah SK, et al. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience. J Gastroenterol Hepatol 2007;22:724-728. https://doi.org/10.1111/j.1440-1746.2007.04935.x
  8. Bal A, Joshi K, Vaiphei K, Wig JD. Primary duodenal neoplasms: a retrospective clinico-pathological analysis. World J Gastroenterol 2007;13:1108-1111. https://doi.org/10.3748/wjg.v13.i7.1108
  9. Lee CC, Ng WK, Lin KW, Lai TW, Li SM. Adenocarcinoma of the duodenum. Hong Kong Med J 2008;14:67-69.
  10. Gonzalez GD, Evans EC. Primary adenocarcinoma of the duodenum. Am Surg 1987;53:174-179.
  11. Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 2007;14:2263-2269. https://doi.org/10.1245/s10434-007-9428-2
  12. Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg 2000;135:635-641. https://doi.org/10.1001/archsurg.135.6.635
  13. Hu JX, Miao XY, Zhong DW, Dai WD, Liu W, Hu W. Surgical treatment of primary duodenal adenocarcinoma. Hepatogastroenterology 2006;53:858-862.
  14. Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg 1998;2:79-87. https://doi.org/10.1016/S1091-255X(98)80107-8
  15. Barnes G Jr, Romero L, Hess KR, Curley SA. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol 1994;1:73-78. https://doi.org/10.1007/BF02303544
  16. Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW. Prognostic factors for primary duodenal adenocarcinoma. World J Surg 2008;32:2246-2252. https://doi.org/10.1007/s00268-008-9678-6
  17. Rotman N, Pezet D, Fagniez PL, Cherqui D, Celicout B, Lointier P. Adenocarcinoma of the duodenum: factors influencing survival. French Association for Surgical Research. Br J Surg 1994;81:83-85. https://doi.org/10.1002/bjs.1800810128
  18. Sexe RB, Wade TP, Virgo KS, Johnson FE. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer 1996;77:251-254. https://doi.org/10.1002/(SICI)1097-0142(19960115)77:2<251::AID-CNCR5>3.0.CO;2-P
  19. Santoro E, Sacchi M, Scutari F, Carboni F, Graziano F. Primary adenocarcinoma of the duodenum: treatment and survival in 89 patients. Hepatogastroenterology 1997;44:1157-1163.
  20. Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518-526. https://doi.org/10.1002/cncr.20404
  21. Brucher BL, Stein HJ, Roder JD, et al. New aspects of prognostic factors in adenocarcinomas of the small bowel. Hepatogastroenterology 2001;48:727-732.
  22. Stell D, Mayer D, Mirza D, Buckels J. Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum. Dig Surg 2004;21:434-438. https://doi.org/10.1159/000083470
  23. Locher C, Malka D, Boige V, et al. Combination chemotherapy in advanced small bowel adenocarcinoma. Oncology 2005;69:290-294. https://doi.org/10.1159/000089678

피인용 문헌

  1. Adenocarcinoma of the third duodenal portion: Case report and review of literature vol.4, pp.1, 2011, https://doi.org/10.4240/wjgs.v4.i1.23
  2. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma vol.398, pp.2, 2013, https://doi.org/10.1007/s00423-012-0978-9
  3. Defining the Role of Adjuvant Therapy: Ampullary and Duodenal Adenocarcinoma vol.24, pp.2, 2011, https://doi.org/10.1016/j.semradonc.2013.11.001
  4. Primary Non-ampullary Duodenal Adenocarcinoma: A Single-center Experience for 15 Years vol.66, pp.4, 2015, https://doi.org/10.4166/kjg.2015.66.4.194
  5. A Resected Case of Mucinous Adenocarcinoma of the Duodenum, Mimicking Intraductal Papillary Neoplasm of the Bile Duct vol.100, pp.11, 2011, https://doi.org/10.9738/intsurg-d-15-00001.1
  6. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes vol.81, pp.11, 2011, https://doi.org/10.1177/000313481508101124
  7. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database vol.8, pp.None, 2011, https://doi.org/10.1038/s41598-018-26145-6
  8. Simple Versus Radical Resection for Duodenal Adenocarcinoma: A Propensity Score Matched Analysis of National Cancer Database vol.87, pp.2, 2011, https://doi.org/10.1177/0003134820951432
  9. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis vol.26, pp.3, 2021, https://doi.org/10.1007/s10147-020-01840-5